Catalyst Wire Dossier Catalyst Wire Dossier

Trehalose Ophthalmic Solution 3%

trehalose ophthalmic solution
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trehalose Ophthalmic Solution 3%, covering 2025-06-15 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function [Phase 4]

See pricing